$PLCE
Childrens Place, Inc.

2024 Q2 Form 10-Q Financial Statement

#000162828024027897 Filed on June 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q2
Revenue $267.9M
YoY Change -16.71%
Cost Of Revenue $175.1M
YoY Change -22.6%
Gross Profit $92.74M
YoY Change -2.76%
Gross Profit Margin 34.62%
Selling, General & Admin $109.1M
YoY Change -0.06%
% of Gross Profit 117.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.64M
YoY Change -1.8%
% of Gross Profit 12.55%
Operating Expenses $109.1M
YoY Change -9.85%
Operating Profit -$27.99M
YoY Change 9.19%
Interest Expense -$7.721M
YoY Change 30.8%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$35.71M
YoY Change -0.73%
Income Tax $2.100M
% Of Pretax Income
Net Earnings -$37.80M
YoY Change 31.08%
Net Earnings / Revenue -14.11%
Basic Earnings Per Share -$2.99
Diluted Earnings Per Share -$2.99
COMMON SHARES
Basic Shares Outstanding 12.69M shares
Diluted Shares Outstanding 12.64M shares

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.96M
YoY Change -28.96%
Cash & Equivalents $12.96M
Short-Term Investments
Other Short-Term Assets $43.21M
YoY Change -26.14%
Inventory $425.2M
Prepaid Expenses
Receivables $28.29M
Other Receivables $0.00
Total Short-Term Assets $509.6M
YoY Change -15.99%
LONG-TERM ASSETS
Property, Plant & Equipment $116.8M
YoY Change -59.88%
Goodwill
YoY Change
Intangibles $41.00M
YoY Change -42.0%
Long-Term Investments
YoY Change
Other Assets $6.957M
YoY Change -85.03%
Total Long-Term Assets $338.7M
YoY Change -17.03%
TOTAL ASSETS
Total Short-Term Assets $509.6M
Total Long-Term Assets $338.7M
Total Assets $848.3M
YoY Change -16.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $193.1M
YoY Change -13.5%
Accrued Expenses $150.5M
YoY Change -22.88%
Deferred Revenue
YoY Change
Short-Term Debt $226.1M
YoY Change -24.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $573.2M
YoY Change -20.31%
LONG-TERM LIABILITIES
Long-Term Debt $166.6M
YoY Change 234.82%
Other Long-Term Liabilities $10.56M
YoY Change -91.2%
Total Long-Term Liabilities $10.56M
YoY Change -93.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $573.2M
Total Long-Term Liabilities $10.56M
Total Liabilities $883.2M
YoY Change -0.66%
SHAREHOLDERS EQUITY
Retained Earnings -$172.7M
YoY Change 1775.75%
Common Stock $1.274M
YoY Change 2.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$34.85M
YoY Change
Total Liabilities & Shareholders Equity $848.3M
YoY Change -16.41%

Cashflow Statement

Concept 2024 Q2
OPERATING ACTIVITIES
Net Income -$37.80M
YoY Change 31.08%
Depreciation, Depletion And Amortization $11.64M
YoY Change -1.8%
Cash From Operating Activities -$110.8M
YoY Change -2257.3%
INVESTING ACTIVITIES
Capital Expenditures $4.694M
YoY Change -57.26%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$4.694M
YoY Change -57.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $114.9M
YoY Change 1381.1%
NET CHANGE
Cash From Operating Activities -$110.8M
Cash From Investing Activities -$4.694M
Cash From Financing Activities $114.9M
Net Change In Cash -$679.0K
YoY Change -136.62%
FREE CASH FLOW
Cash From Operating Activities -$110.8M
Capital Expenditures $4.694M
Free Cash Flow -$115.5M
YoY Change 1874.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
166635000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
49818000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
118363000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
118073000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87905000 usd
CY2024Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
9486000 usd
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
17199000 usd
CY2024Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4928000 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4664000 usd
CY2023Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
2885000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10557000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10882000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12005000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
883185000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
809327000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
889049000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12739000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12585000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12473000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12679000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12529000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12405000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1274000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1259000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1247000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153358000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
60000 shares
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
800308000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1014870000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-37795000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
158478000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
6088000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
49768000 usd
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
9486000 usd
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
141083000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150846000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
56000 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
68000 shares
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2957000 usd
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2909000 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3810000 usd
CY2024Q2 plce Deferred Compensation
DeferredCompensation
2957000 usd
CY2024Q1 plce Deferred Compensation
DeferredCompensation
2909000 usd
CY2023Q2 plce Deferred Compensation
DeferredCompensation
3810000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16822000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16496000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17065000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
267878000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-134865000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9207000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-34850000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9019000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
125821000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
848335000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
321640000 usd
CY2024 us-gaap Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#AssetImpairmentCharges
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172660000 usd
CY2024Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
175137000 usd
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
225178000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
92741000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
96462000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109094000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
112931000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11635000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11848000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1750000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27988000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-30067000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
7731000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5937000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
34000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35709000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35970000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2086000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7136000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-37795000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-28834000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.99
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.33
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.99
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.33
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12643000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12374000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12643000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12643000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12374000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12374000 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-37795000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-28834000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-326000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-818000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38121000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29652000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9019000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12610000 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
320000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-326000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-34850000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3083000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-37795000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-28834000 usd
CY2024Q2 plce Operating Lease Expense Noncash
OperatingLeaseExpenseNoncash
19212000 usd
CY2023Q2 plce Operating Lease Expense Noncash
OperatingLeaseExpenseNoncash
18441000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11635000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11848000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12610000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3083000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1750000 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
112000 usd
CY2024Q2 plce Other Non Cash Charges Net
OtherNonCashChargesNet
361000 usd
CY2023Q2 plce Other Non Cash Charges Net
OtherNonCashChargesNet
149000 usd
CY2024Q2 plce Number Of Countries For Distribution
NumberOfCountriesForDistribution
16 country
CY2024Q2 plce Number Of International Franchise Partners
NumberOfInternationalFranchisePartners
6 partner
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63452000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
57085000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-5565000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-25239000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2250000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-641000 usd
CY2024Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5783000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-9697000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-45987000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
61598000 usd
CY2024Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-16117000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-20874000 usd
CY2024Q2 plce Increase Decrease In Deferred And Other Liabilities
IncreaseDecreaseInDeferredAndOtherLiabilities
-321000 usd
CY2023Q2 plce Increase Decrease In Deferred And Other Liabilities
IncreaseDecreaseInDeferredAndOtherLiabilities
-1237000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-110756000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5134000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4694000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10982000 usd
CY2024Q2 us-gaap Payments For Proceeds From Life Insurance Policies
PaymentsForProceedsFromLifeInsurancePolicies
0 usd
CY2023Q2 us-gaap Payments For Proceeds From Life Insurance Policies
PaymentsForProceedsFromLifeInsurancePolicies
55000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4694000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11037000 usd
CY2024Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
248035000 usd
CY2023Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
135583000 usd
CY2024Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
248649000 usd
CY2023Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
121738000 usd
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
320000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6088000 usd
CY2024Q2 plce Proceeds From Term Loan Net Of Discount
ProceedsFromTermLoanNetOfDiscount
168600000 usd
CY2023Q2 plce Proceeds From Term Loan Net Of Discount
ProceedsFromTermLoanNetOfDiscount
0 usd
CY2024Q2 us-gaap Repayments Of Longterm Loans From Vendors
RepaymentsOfLongtermLoansFromVendors
50000000 usd
CY2023Q2 us-gaap Repayments Of Longterm Loans From Vendors
RepaymentsOfLongtermLoansFromVendors
0 usd
CY2024Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2777000 usd
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
114889000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7757000 usd
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-118000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-301000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-679000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1553000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13639000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16689000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12960000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18242000 usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-3715000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2293000 usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
7591000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
5784000 usd
CY2024Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5849000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7151000 usd
CY2024Q2 plce Number Of Digital Storefronts
NumberOfDigitalStorefronts
2 digital_storefront
CY2024Q2 us-gaap Number Of Stores
NumberOfStores
500 store
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172700000 usd
CY2024Q2 plce Working Capital Deficit
WorkingCapitalDeficit
63600000 usd
CY2024Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year</span></div>The Company’s fiscal year is a fifty-two week or fifty-three week period ending on the Saturday on or nearest to January 31.
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and amounts of revenues and expenses reported during the period. Actual results could differ from the assumptions used and estimates made by management, which could have a material impact on the Company’s financial position or results of operations. Critical accounting estimates inherent in the preparation of the consolidated financial statements include impairment of long-lived assets, impairment of indefinite-lived intangible assets, income taxes, stock-based compensation, and inventory valuation.</span></div>
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
267878000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
321640000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5500000 usd
CY2024Q2 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
1300000 usd
CY2024Q1 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
1700000 usd
CY2023Q2 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
1800000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2300000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1700000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3800000 usd
CY2024Q2 plce Lessee Operating Lease Number Of Renewal Options
LesseeOperatingLeaseNumberOfRenewalOptions
2 segment
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.20
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
2300000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
2308000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
1666000 usd
CY2024Q2 plce Restructuring Charges Excluding Noncash Restructuring Charges And Accelerated Depreciation
RestructuringChargesExcludingNoncashRestructuringChargesAndAcceleratedDepreciation
751000 usd
CY2024Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
1361000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
1056000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2023Q3 plce Restructuring Charges Excluding Noncash Restructuring Charges And Accelerated Depreciation
RestructuringChargesExcludingNoncashRestructuringChargesAndAcceleratedDepreciation
9659000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
6642000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
3017000 usd
CY2023Q4 plce Restructuring Charges Excluding Noncash Restructuring Charges And Accelerated Depreciation
RestructuringChargesExcludingNoncashRestructuringChargesAndAcceleratedDepreciation
756000 usd
CY2023Q4 us-gaap Payments For Restructuring
PaymentsForRestructuring
2920000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
853000 usd
plce Restructuring Charges Excluding Noncash Restructuring Charges And Accelerated Depreciation
RestructuringChargesExcludingNoncashRestructuringChargesAndAcceleratedDepreciation
1275000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
462000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
1666000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
45000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4000000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41000000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
45000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3877000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41123000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
73953000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3262000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
70691000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
797288000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
804131000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
858260000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
680509000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
679381000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
711945000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116779000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124750000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
146315000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1800000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
22502000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
20906000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
7846000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
14697000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
30348000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
35603000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.076
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
19700000 usd
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
22100000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
66253000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
59954000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
31507000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
16113000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13931000 usd
CY2024Q2 plce Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
40603000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
228361000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
39330000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
189031000 usd
CY2024Q2 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
228200000 usd
CY2024 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
315500000 usd
CY2023Q2 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
297100000 usd
CY2024Q2 us-gaap Line Of Credit Facility Maximum Amount Outstanding During Period
LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
251600000 usd
CY2024 us-gaap Line Of Credit Facility Maximum Amount Outstanding During Period
LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
379400000 usd
CY2023Q2 us-gaap Line Of Credit Facility Maximum Amount Outstanding During Period
LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
305900000 usd
CY2024Q2 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.096
CY2024 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.075
CY2023Q2 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.059
CY2024Q2 us-gaap Schedule Of Repurchase Agreements
ScheduleOfRepurchaseAgreements
<div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s share repurchases:</span></div><div style="margin-bottom:3pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thirteen Weeks Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">May 4, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Share repurchases related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares acquired and held in treasury</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>
CY2024Q2 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
43000 shares
CY2024Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
320000 usd
CY2023Q2 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
155000 shares
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6088000 usd
CY2024Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4000 shares
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
48000 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1000 shares
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
74000 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
78000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
228000 shares
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12610000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3083000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-37795000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-28834000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12643000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12374000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12643000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12643000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12374000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12374000 shares
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1800000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q2 plce Impairment Charges100 Basis Point Increase In Discount Rate
ImpairmentCharges100BasisPointIncreaseInDiscountRate
3000000 usd
CY2024Q2 plce Impairment Charges10 Decrease In Forecasted Revenue
ImpairmentCharges10DecreaseInForecastedRevenue
4000000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.058
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.198
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7100000 usd
CY2020Q1 plce Carryovers And Carrybacks To Offset
CarryoversAndCarrybacksToOffset
1
CY2021 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
150000000 usd
CY2024Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
19100000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7400000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3800000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
267878000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
321640000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27988000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-30067000 usd
CY2024Q2 plce Operating Income Loss To Net Sales Percentage
OperatingIncomeLossToNetSalesPercentage
-0.104
CY2023Q2 plce Operating Income Loss To Net Sales Percentage
OperatingIncomeLossToNetSalesPercentage
-0.093
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11635000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11848000 usd
CY2024Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
4694000 usd
CY2023Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
10982000 usd

Files In Submission

Name View Source Status
0001628280-24-027897-index-headers.html Edgar Link pending
0001628280-24-027897-index.html Edgar Link pending
0001628280-24-027897.txt Edgar Link pending
0001628280-24-027897-xbrl.zip Edgar Link pending
clawbackpolicy-approvedaug.htm Edgar Link pending
exhibit3112024q1.htm Edgar Link pending
exhibit3122024q1.htm Edgar Link pending
exhibit322024q1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_0b.jpg Edgar Link pending
insidertradingpolicyadopte.htm Edgar Link pending
jelfersseparationagreeme.htm Edgar Link pending
jelfersseparationagreeme001.jpg Edgar Link pending
jelfersseparationagreeme002.jpg Edgar Link pending
jelfersseparationagreeme003.jpg Edgar Link pending
jelfersseparationagreeme004.jpg Edgar Link pending
jelfersseparationagreeme005.jpg Edgar Link pending
jelfersseparationagreeme006.jpg Edgar Link pending
jelfersseparationagreeme007.jpg Edgar Link pending
jelfersseparationagreeme008.jpg Edgar Link pending
jelfersseparationagreeme009.jpg Edgar Link pending
jelfersseparationagreeme010.jpg Edgar Link pending
jelfersseparationagreeme011.jpg Edgar Link pending
jelfersseparationagreeme012.jpg Edgar Link pending
jelfersseparationagreeme013.jpg Edgar Link pending
jelfersseparationagreeme014.jpg Edgar Link pending
jelfersseparationagreeme015.jpg Edgar Link pending
jelfersseparationagreeme016.jpg Edgar Link pending
jelfersseparationagreeme017.jpg Edgar Link pending
jelfersseparationagreeme018.jpg Edgar Link pending
jelfersseparationagreeme019.jpg Edgar Link pending
jelfersseparationagreeme020.jpg Edgar Link pending
jelfersseparationagreeme021.jpg Edgar Link pending
jelfersseparationagreeme022.jpg Edgar Link pending
jelfersseparationagreeme023.jpg Edgar Link pending
jelfersseparationagreeme024.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
offerofemployment-muhammad.htm Edgar Link pending
plce-20240504.htm Edgar Link pending
plce-20240504.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
plce-20240504_def.xml Edgar Link unprocessable
plce-20240504_htm.xml Edgar Link completed
plce-20240504_lab.xml Edgar Link unprocessable
plce-20240504_pre.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
plce-20240504_cal.xml Edgar Link unprocessable